Jennifer Carver's Restricted Stock Grant in Revelation Biosciences, Inc.

On October 29, 2025, Jennifer Carver, a director of Revelation Biosciences, Inc., was granted 15,625 shares of common stock under the company's 2021 Equity Incentive Plan. The shares were granted at a price of $1.28 per share and are set to vest fully on January 28, 2026. Following this transaction, Carver's total holdings in the company increased to 15,688 shares. The grant is classified as a restricted stock grant and is directly owned by Carver. This filing was reported on October 30, 2025, and signed by J.P. Galda as attorney-in-fact for Jennifer Carver.